Apoptosis of bystander uninfected CD4+ T lymphocytes by neighboring HIV-infected cells is observed in cell culture and in lymphoid tissue of HIV-infected individuals. This study addresses whether antigen-presenting cells such as human macrophages mediate apoptosis of CD4+ T cells from HIV-infected individuals. Uninfected human macrophages, and to a larger degree, HIV-infected macrophages mediate apoptosis of T cells from HIV-infected, but not from uninfected control individuals. This macrophage-dependent killing targets CD4+, but not CD8+ T lymphocytes from HIV-infected individuals, and direct contact between macrophages and lymphocytes is required. Additional analyses indicated that the apoptosis-inducing ligands, FasL and tumor necrosis factor (TNF), mediate this macrophage-induced apoptosis of CD4+ T cells. These results support a role for macrophage-associated FasL and TNF in the selective depletion of CD4+ T cells in HIV-infected individuals.
Skip Nav Destination
Article navigation
6 January 1997
Article|
January 01 1997
Macrophage-dependent Apoptosis of CD4+ T Lymphocytes from HIV-infected Individuals Is Mediated by FasL and Tumor Necrosis Factor
Andrew D. Badley,
Andrew D. Badley
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
David Dockrell,
David Dockrell
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Margaret Simpson,
Margaret Simpson
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Ron Schut,
Ron Schut
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
David H. Lynch,
David H. Lynch
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Paul Leibson,
Paul Leibson
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Carlos V. Paya
Carlos V. Paya
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Search for other works by this author on:
Andrew D. Badley
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
David Dockrell
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Margaret Simpson
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Ron Schut
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
David H. Lynch
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Paul Leibson
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Carlos V. Paya
From the *Division of Infectious Diseases, ¶Division of Experimental Pathology, and ‖Department of Immunology, Mayo Clinic, Rochester, Minnesota 55901; ‡Division of Infectious Diseases, Hennepin County Medical Center, Minneapolis, Minnesota 55404; and §Immunex Corporation, Seattle, Washington 98101
Address correspondence to Dr. Carlos V. Paya, Division of Infectious Diseases, Mayo Clinic, 200 First Street SW, Guggenheim 501, Rochester, MN 55905.
We would like to acknowledge the excellent secretarial assistance of Mr. Douglas Hauschild.
Drs. Badley and Dockrell contributed equally to this work.
1Abbreviation used in this paper: MDM, monocyte derived macrophage.
Received:
August 14 1996
Revision Received:
October 29 1996
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1997
J Exp Med (1997) 185 (1): 55–64.
Article history
Received:
August 14 1996
Revision Received:
October 29 1996
Citation
Andrew D. Badley, David Dockrell, Margaret Simpson, Ron Schut, David H. Lynch, Paul Leibson, Carlos V. Paya; Macrophage-dependent Apoptosis of CD4+ T Lymphocytes from HIV-infected Individuals Is Mediated by FasL and Tumor Necrosis Factor. J Exp Med 6 January 1997; 185 (1): 55–64. doi: https://doi.org/10.1084/jem.185.1.55
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement